Literature DB >> 32175256

Energy-based devices for hemostasis in thyroid surgery.

Aleksander Konturek1, Bartłomiej Szpyra2, Małgorzata Stopa-Barczyńska1, Marcin Barczyński1.   

Abstract

The evolution of operative techniques in thyroid surgery that has taken place over the past several decades would not have been possible if not for a sui generis revolution in surgery at the turn of the 19th and 20th centuries. The three most important events of the end of the 19th century, i.e., the introduction of anesthesia, the use of artery forceps and ligation of blood vessels, as well as prophylactic management of perioperative infections decidedly affected the improvement of therapeutic results of thyroid surgery. Surgical treatment of thyroid diseases is associated with the possibility of complications developing, of which bleeding is among the most serious ones, starting from the need for an immediate reoperation and ending at a considerable damage to functionally important structures: the laryngeal nerves and parathyroid glands. The consensus reached between the development of science and progress in modern technologies has provided the basis for introducing and popularizing minimally invasive procedures, including operations using the approach through natural body openings. Such an unprecedented development of surgical techniques would not be possible without devices for closing blood vessels. Given the mechanism of hemostasis, current vascular sealing devices can generally be divided into three groups: ultrasonic, bipolar-radiofrequency and hybrid systems combining both energy modalities. While analyzing the innovative, advanced technology of all the energy-based devices, it should be stated that only if they are used in a safe manner, quality of life of patients with various thyroid conditions is improved. The employment of such devices fully confirms their usefulness; nevertheless, all the advantages should never release the surgeon from the obligation to appropriately and safely identify the surrounding structures and let him uncritically use the new device. 2020 Gland Surgery. All rights reserved.

Entities:  

Keywords:  Thyroidectomy; hemostatic agents; new energy based devices

Year:  2020        PMID: 32175256      PMCID: PMC7044082          DOI: 10.21037/gs.2019.10.17

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  5 in total

1.  The use of self-assembling peptides (PuraStat) for hemostasis in cervical endocrine surgery. A real-life case series of 353 patients.

Authors:  Y Gangner; M Bagot d'Arc; C Delin
Journal:  Int J Surg Case Rep       Date:  2022-04-12

2.  The Use of Harmonic Focus and Thunderbeat Open Fine Jaw in Thyroid Surgery: Experience of a High-Volume Center.

Authors:  Gian Luigi Canu; Fabio Medas; Federico Cappellacci; Francesco Casti; Raffaela Bura; Enrico Erdas; Pietro Giorgio Calò
Journal:  J Clin Med       Date:  2022-05-29       Impact factor: 4.964

3.  The Application Value of the Central Lymph Node Metastasis Risk Assessment Model in Papillary Thyroid Microcarcinoma of Stage cN0: A Study of 828 Patients.

Authors:  Jinqiu Wang; Xianneng Sheng; Yongping Dai; Jiabo Zhang; Lihua Song; Yu Guo
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-10       Impact factor: 6.055

4.  Novel application of microdissection tungsten needle in total thyroidectomy with central neck dissection for papillary thyroid carcinoma.

Authors:  Weijie Zheng; Shan Zhu; Yimin Zhang; Zhong Wang; Shichong Liao; Shengrong Sun
Journal:  Front Surg       Date:  2022-08-26

Review 5.  Differentiated Thyroid Cancer: A Health Economic Review.

Authors:  Klaas Van Den Heede; Neil S Tolley; Aimee N Di Marco; Fausto F Palazzo
Journal:  Cancers (Basel)       Date:  2021-05-07       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.